These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29969703)

  • 1. No evidence in support of a prodromal respiratory control signature in the TgF344-AD rat model of Alzheimer's disease.
    Lucking EF; Murphy KH; Burns DP; Jaisimha AV; Barry-Murphy KJ; Dhaliwal P; Boland B; Rae MG; O'Halloran KD
    Respir Physiol Neurobiol; 2019 Jul; 265():55-67. PubMed ID: 29969703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
    Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
    J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study.
    Anckaerts C; Blockx I; Summer P; Michael J; Hamaide J; Kreutzer C; Boutin H; Couillard-Després S; Verhoye M; Van der Linden A
    Neurobiol Dis; 2019 Apr; 124():93-107. PubMed ID: 30445024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology.
    Stoiljkovic M; Kelley C; Stutz B; Horvath TL; Hajós M
    Cereb Cortex; 2019 Jun; 29(6):2716-2727. PubMed ID: 29920597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological signals as predictive translational biomarkers for Alzheimer's disease treatment: effects of donepezil on neuronal network oscillations in TgF344-AD rats.
    Stoiljkovic M; Kelley C; Horvath TL; Hajós M
    Alzheimers Res Ther; 2018 Oct; 10(1):105. PubMed ID: 30301466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early ultrasonic vocalization deficits and related thyroarytenoid muscle pathology in the transgenic TgF344-AD rat model of Alzheimer's disease.
    Rudisch DM; Krasko MN; Barnett DGS; Mueller KD; Russell JA; Connor NP; Ciucci MR
    Front Behav Neurosci; 2023; 17():1294648. PubMed ID: 38322496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic fornix deep brain stimulation in a transgenic Alzheimer's rat model reduces amyloid burden, inflammation, and neuronal loss.
    Leplus A; Lauritzen I; Melon C; Kerkerian-Le Goff L; Fontaine D; Checler F
    Brain Struct Funct; 2019 Jan; 224(1):363-372. PubMed ID: 30341742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Gamma Stimulation Improves Activity but not Memory in Aged Tgf344-AD Rats.
    Bentley JH; Broussard JI
    Curr Alzheimer Res; 2024; 20(11):769-777. PubMed ID: 38445702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer's disease rats.
    Mampay M; Velasco-Estevez M; Rolle SO; Chaney AM; Boutin H; Dev KK; Moeendarbary E; Sheridan GK
    FEBS Open Bio; 2021 Jan; 11(1):146-163. PubMed ID: 33185010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.
    Morrone CD; Lai AY; Bishay J; Hill ME; McLaurin J
    Transl Neurodegener; 2022 May; 11(1):26. PubMed ID: 35501886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats.
    van den Berg M; Adhikari MH; Verschuuren M; Pintelon I; Vasilkovska T; Van Audekerke J; Missault S; Heymans L; Ponsaerts P; De Vos WH; Van der Linden A; Keliris GA; Verhoye M
    Alzheimers Res Ther; 2022 Oct; 14(1):148. PubMed ID: 36217211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
    Kelberman MA; Rorabaugh JM; Anderson CR; Marriott A; DePuy SD; Rasmussen K; McCann KE; Weiss JM; Weinshenker D
    Neurobiol Aging; 2023 May; 125():98-108. PubMed ID: 36889122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.
    Smith LA; McMahon LL
    Neurobiol Dis; 2018 Feb; 110():166-179. PubMed ID: 29199135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer's rats.
    Chaudry O; Ndukwe K; Xie L; Figueiredo-Pereira M; Serrano P; Rockwell P
    Sci Rep; 2022 Nov; 12(1):19129. PubMed ID: 36352024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
    Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
    Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of chronic stress on anxiety-like behavior and contextual fear conditioning in the TgF344-AD rat model of Alzheimer's disease.
    Pentkowski NS; Bouquin SJ; Maestas-Olguin CR; Villasenor ZM; Clark BJ
    Behav Brain Res; 2022 Feb; 418():113661. PubMed ID: 34780859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.
    Kelberman MA; Anderson CR; Chlan E; Rorabaugh JM; McCann KE; Weinshenker D
    J Alzheimers Dis; 2022; 86(3):1037-1059. PubMed ID: 35147547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of continuous and intermittent ketogenic diets on cognitive behavior, motor function, and blood lipids in TgF344-AD rats.
    Rutkowsky JM; Roland Z; Valenzuela A; Nguyen AB; Park HH; Six N; Dursun I; Kim K; Lein PJ; Ramsey JJ
    Aging (Albany NY); 2024 Apr; 16(7):5811-5828. PubMed ID: 38613791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.